ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012

Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops

August 28, 1987

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

FASEB Urges 6.7 Percent Increase In NIH Budget.

February 1, 2008

NCI CTEP-Approved Trials For the Month of February

February 28, 2014